UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Reactive Oxygen Species-Triggered Dissociation of a Polyrotaxane-Based Nanochelator for Enhanced Clearance of Systemic and Hepatic Iron

ACS nano, 2021-01, Vol.15 (1), p.419-433

2021

Volltextzugriff (PDF)

Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms

Applied materials today, 2021-03, Vol.22, p.100887-100887, Article 100887

2021

Volltextzugriff (PDF)

Copalic acid analogs down-regulate androgen receptor and inhibit small chaperone protein

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2292-2295

2017

Volltextzugriff (PDF)

Synthesis and biological evaluation of anti-cancer agents that selectively inhibit Her2 over-expressed breast cancer cell growth via down-regulation of Her2 protein

Bioorganic & medicinal chemistry letters, 2018-02, Vol.28 (4), p.727-731

2018

Volltextzugriff (PDF)

Development of Novel Amphotericin B‑Immobilized Nitric Oxide-Releasing Platform for the Prevention of Broad-Spectrum Infections and Thrombosis

ACS applied materials & interfaces, 2021-05, Vol.13 (17), p.19613-19624

2021

Volltextzugriff (PDF)

Combination strategies for antithrombotic biomaterials: an emerging trend towards hemocompatibility

Biomaterials science, 2021-04, Vol.9 (7), p.2413-2423

2021

Volltextzugriff (PDF)

Superhydrophobic and Conductive Foams with Antifouling and Oil–Water Separation Properties

ACS applied materials & interfaces, 2023-02, Vol.15 (5), p.7610-7626

2023

Volltextzugriff (PDF)

Derivatization of graphene oxide nanosheets with tunable nitric oxide release for antibacterial biomaterials

Journal of biomedical materials research. Part A, 2023-04, Vol.111 (4), p.451-464

2023

Volltextzugriff (PDF)

Formulation Versatility of Nitric Oxide Donor Molecules for the Prevention of Medical Device-Associated Complications

Ashcraft, Morgan

2022

Volltextzugriff (PDF)

Dual Action Nitric Oxide and Fluoride Ion-Releasing Hydrogels for Combating Dental Caries

ACS applied materials & interfaces, 2022-05, Vol.14 (19), p.21916-21930

2022

Volltextzugriff (PDF)

Desferrioxamine:gallium-pluronic micelles increase outer membrane permeability and potentiate antibiotic activity against Pseudomonas aeruginosa

Chemical communications (Cambridge, England), 2018-12, Vol.54 (99), p.13929-13932

2018

Volltextzugriff (PDF)

Bioinspired superhydrophobic surfaces with silver and nitric oxide-releasing capabilities to prevent device-associated infections and thrombosis

Journal of colloid and interface science, 2024-06, Vol.664, p.928-937

2024

Volltextzugriff (PDF)

Reduction in Foreign Body Response and Improved Antimicrobial Efficacy via Silicone-Oil-Infused Nitric-Oxide-Releasing Medical-Grade Cannulas

ACS applied materials & interfaces, 2021-11, Vol.13 (44), p.52425-52434

2021

Volltextzugriff (PDF)

Desferrioxamine:gallium-pluronic micelles increase outer membrane permeability and potentiate antibiotic activity against Pseudomonas aeruginosaElectronic supplementary information (ESI) available. See DOI: 10.1039/c8cc08134d

2018-12

Volltextzugriff (PDF)

Nitric Oxide-Releasing Lock Solution for the Prevention of Catheter-Related Infection and Thrombosis

ACS applied bio materials, 2022-04, Vol.5 (4), p.1519-1527

2022

Volltextzugriff (PDF)

Surface Engineering for Endothelium‐Mimicking Functions to Combat Infection and Thrombosis in Extracorporeal Life Support Technologies

Advanced healthcare materials, 2024-07, p.e2400492

2024

Volltextzugriff (PDF)

Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy

Journal of medicinal chemistry, 2021-10, Vol.64 (19), p.14142-14152

2021

Volltextzugriff (PDF)

Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of [ 14 C]aficamten following single oral dose administration to rats

Xenobiotica, 2024-08, p.1-16

2024

Volltextzugriff (PDF)

Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of 14Caficamten following single oral dose administration to rats

Xenobiotica, 2024-08, p.1

2024

Volltextzugriff (PDF)

In vitro and in vivo preclinical pharmacokinetic characterization of aficamten, a small molecule cardiac myosin inhibitor

Xenobiotica, 2024-08, p.1-15

2024

Volltextzugriff (PDF)

Cardiac Troponin Activator CK-963 Increases Cardiac Contractility in Rats

Journal of medicinal chemistry, 2024-05, Vol.67 (10), p.7859-7869

2024

Volltextzugriff (PDF)

Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility

Journal of medicinal chemistry, 2024-05, Vol.67 (10), p.7825-7835

2024

Volltextzugriff (PDF)

Discovery of Reldesemtiv, a Fast Skeletal Muscle Troponin Activator for the Treatment of Impaired Muscle Function

Journal of medicinal chemistry, 2021-10, Vol.64 (20), p.14930-14941

2021

Volltextzugriff (PDF)

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295

ACS medicinal chemistry letters, 2010-04, Vol.1 (1), p.30-34

2010

Volltextzugriff (PDF)

Using Loan Rates to Measure and Regulate Bank Risk: Findings and an Immodest Proposal

Journal of financial services research, 2003-10, Vol.24 (2), p.181-200

2003

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)
Dissertationen
(1)

Sprache

Englisch
(26)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(10)
Life Sciences & Biomedicine
(9)
Materials Science
(9)
Pharmacology & Pharmacy
(9)
Technology
(9)
Chemistry, Medicinal
(7)
Nanoscience & Nanotechnology
(6)
Nitric Oxide
(6)
Science & Technology - Other Topics
(6)
Chemistry
(5)
Materials Science, Multidisciplinary
(5)
Physical Sciences
(5)
Structure-Activity Relationship
(5)
Antimicrobial
(4)
Materials Science, Biomaterials
(4)
Animals
(3)
Antifouling
(3)
Drug Discovery
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Reactive Oxygen Species-Triggered Dissociation of a Polyrotaxane-Based Nanochelator for Enhanced Clearance of Systemic and Hepatic Iron

Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms

Copalic acid analogs down-regulate androgen receptor and inhibit small chaperone protein

Synthesis and biological evaluation of anti-cancer agents that selectively inhibit Her2 over-expressed breast cancer cell growth via down-regulation of Her2 protein

Development of Novel Amphotericin B‑Immobilized Nitric Oxide-Releasing Platform for the Prevention of Broad-Spectrum Infections and Thrombosis

Combination strategies for antithrombotic biomaterials: an emerging trend towards hemocompatibility

Superhydrophobic and Conductive Foams with Antifouling and Oil–Water Separation Properties

Derivatization of graphene oxide nanosheets with tunable nitric oxide release for antibacterial biomaterials

Formulation Versatility of Nitric Oxide Donor Molecules for the Prevention of Medical Device-Associated Complications

Dual Action Nitric Oxide and Fluoride Ion-Releasing Hydrogels for Combating Dental Caries

Desferrioxamine:gallium-pluronic micelles increase outer membrane permeability and potentiate antibiotic activity against Pseudomonas aeruginosa

Bioinspired superhydrophobic surfaces with silver and nitric oxide-releasing capabilities to prevent device-associated infections and thrombosis

Reduction in Foreign Body Response and Improved Antimicrobial Efficacy via Silicone-Oil-Infused Nitric-Oxide-Releasing Medical-Grade Cannulas

Desferrioxamine:gallium-pluronic micelles increase outer membrane permeability and potentiate antibiotic activity against Pseudomonas aeruginosaElectronic supplementary information (ESI) available. See DOI: 10.1039/c8cc08134d

Nitric Oxide-Releasing Lock Solution for the Prevention of Catheter-Related Infection and Thrombosis

Surface Engineering for Endothelium‐Mimicking Functions to Combat Infection and Thrombosis in Extracorporeal Life Support Technologies

Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy

Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of [ 14 C]aficamten following single oral dose administration to rats

Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of 14Caficamten following single oral dose administration to rats

In vitro and in vivo preclinical pharmacokinetic characterization of aficamten, a small molecule cardiac myosin inhibitor

Cardiac Troponin Activator CK-963 Increases Cardiac Contractility in Rats

Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility

Discovery of Reldesemtiv, a Fast Skeletal Muscle Troponin Activator for the Treatment of Impaired Muscle Function

Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295

Using Loan Rates to Measure and Regulate Bank Risk: Findings and an Immodest Proposal

Suchergebnisse filtern